Antiproliferative synergism of azasterols and antifolates against Toxoplasma gondii.
The antiproliferative effects of two azasterols, 22,26-azasterol (20-piperidin-2-yl-5alpha-pregnan-3beta-20(R,S)-diol, AZA) and 24,25(R,S)-epiminolanosterol (EIL), in combination with sulphadiazine (SDZ) and pyrimethamine (PYR) were studied against Toxoplasma gondii tachyzoites growing in cultured mammalian cells. We had previously shown that AZA and EIL, two known inhibitors of Delta24(25)sterol methyl transferase in fungi and protozoa, have a potent and selective anti-T. gondii activity, although no 24-alkyl sterols have been detected in this parasite. We now report that when these sterol analogues were used in combination with the conventional SDZ/PYR treatment, potent synergistic effects were observed, ranging from 10- to 100-fold reductions of the IC50 values in the presence of sub-optimal doses of azasterols. When exposed to these drug combinations, intracellular T. gondii parasites displayed diverse subcellular alterations, including mitochondrial swelling, the arrest of the endodiogeny process with fragmented nuclei and subsequent cell lysis. These results suggest a potential new approach for the treatment of toxoplasmosis, which could significantly lower the required levels of antifolates and thus their adverse side effects.
Dantas-Leite
Lucas
L
Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Bloco G, CCS, Universidade Federal do Rio de Janeiro, 21949-9000 Rio de Janeiro, RJ, Brazil.
Urbina
Julio A
JA
de Souza
Wanderley
W
Vommaro
Rossiane C
RC
D000818:Animals; D002460:Cell Line; D004083:Cholestanol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D003049:Coccidiostats / Q000494:pharmacology*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D006790:Host-Parasite Interactions; D007810:Lanosterol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D008253:Macaca mulatta; D021261:Parasitic Sensitivity Tests; D011739:Pyrimethamine / Q000494:pharmacology; D013411:Sulfadiazine / Q000494:pharmacology; D014122:Toxoplasma / Q000187:drug effects* / Q000254:growth & development*
C103731:22,26-azasterol; D003049:Coccidiostats; D005493:Folic Acid Antagonists; D013411:Sulfadiazine; C059162:24,25-iminolanosterol; D007810:Lanosterol; D004083:Cholestanol; D011739:Pyrimethamine